KangLaiTe USA

Manufacturing · California, United States · 11-50 Employees

View Company Info for Free

Overview

Headquarters

203 Redwood Shores Pkwy Ste 200, Redwood...

Phone Number

(650) 226-8228

Revenue

<$5 Million

Industry

Manufacturing Pharmaceuticals Business Services Research & Development
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1

About KangLaiTe USA

KangLaiTe USA (KLT USA) is a privately held biotechnology company developing a treatment for solid tumors and for cancer-associated anorexia-cachexia syndrome. Our Management Team consists of industry leaders with extensive experience in the pharmaceutical industry. In 1995, the company's lead product under development, Kanglaite Injection (KLTi), was approved by the Chinese Ministry of Health for the treatment of patients with advanced non-small cell lung cancer (NSCLC) and hepatocellular cancer, and it was approved in Russia for treatment of patients with advanced NSCLC in 2003. Today the company holds three open Investigational New Drug applications (INDs) with the U.S. Food & Drug Administration (FDA) for indications related to the treatment of cancer, and KLTi has just completed a phase II clinical trial in the U.S. The company's mission is to discover and develop natural therapies to improve the lives of people living with various cancers, including pancreatic cancer and prostateRead more
Popular SearchesKanglaite UsaKanglaite Usa IncKanglaiteusaKangLaiTe-USAKanglaite - USA Sciences IncSIC Code 28,283NAICS Code 32,325Show more

Is KangLaiTe USA your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to KangLaiTe USA

Compare insights from companies similar to KangLaiTe USA, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

KangLaiTe USA

<$5M
11-50
Private
-
2002
N/A
<$5M
11-50
Private
-
-
N/A
<$5M
11-50
Private
-
-
N/A
<$5M
1-10
Private
-
2018
EB
Evelio BorobioChairman & CEO
<$5M
1-10
Private
-
2003
N/A
<$5M
1-10
Private
-
2009
N/A
Illustration of an envelope

Company Profile Activity

i

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

KangLaiTe USA is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

KangLaiTe USA is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about KangLaiTe USA.

KangLaiTe USA Tech Stack

A closer look at the technologies used by KangLaiTe USA

See more technologies

Top Manufacturing Companies

Frequently Asked Questions Regarding KangLaiTe USA

What is KangLaiTe USA's official website?
KangLaiTe USA's official website is www.kanglaiteusa.com
What is KangLaiTe USA's Revenue?
KangLaiTe USA's revenue is <$5 Million
What is KangLaiTe USA's SIC code?
KangLaiTe USA's SIC: 28,283
What is KangLaiTe USA's NAICS code?
KangLaiTe USA's NAICS: 32,325
How many employees does KangLaiTe USA have?
KangLaiTe USA has 11-50 employees
What industry does KangLaiTe USA belong to?
KangLaiTe USA is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What is KangLaiTe USA competition?
KangLaiTe USA top competitors include: Oncology Newswatch, Nelum, Lauren Sharaby, World Cancer Institute
What technology does KangLaiTe USA use?
Some of the popular technologies that KangLaiTe USA uses are: GoDaddy DNS
How do I contact KangLaiTe USA?
KangLaiTe USA contact info: Phone number: (650) 226-8228 Website: www.kanglaiteusa.com
What does KangLaiTe USA do?

KangLaiTe USA (KLT USA) is a privately held biotechnology company developing a treatment for solid tumors and for cancer-associated anorexia-cachexia syndrome. Our Management Team consists of industry leaders with extensive experience in the pharmaceutical industry. In 1995, the company's lead product under development, Kanglaite Injection (KLTi),... was approved by the Chinese Ministry of Health for the treatment of patients with advanced non-small cell lung cancer (NSCLC) and hepatocellular cancer, and it was approved in Russia for treatment of patients with advanced NSCLC in 2003. Today the company holds three open Investigational New Drug applications (INDs) with the U.S. Food & Drug Administration (FDA) for indications related to the treatment of cancer, and KLTi has just completed a phase II clinical trial in the U.S. The company's mission is to discover and develop natural therapies to improve the lives of people living with various cancers, including pancreatic cancer and prostate cancer.Read More

Is KangLaiTe USA a public company?
KangLaiTe USA is private company therefore does not currently have an official ticker symbol
See more information about KangLaiTe USA

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.